Posts by Sandra Ansanay-Alex
Siegfried opens new global R&D Center for Drug Substances in Evionnaz
Siegfried (SIX: SFZN), a leading global Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry headquartered in Zofingen (Switzerland), inaugurated its new global Research and Development (R&D) Center for Drug Substances at its site in Evionnaz, Switzerland. The 4,500m2 R&D Center houses advanced chemical and analytical facilities, state-of-the-art laboratories, and cutting-edge technologies such…
Read MoreThe Swiss Cancer Centre Léman receives the BioAlps Academia Award 2024
The BioAlps Awards ceremony took place on 21 November 2024 at the University of Fribourg in front about 250 key players from the Swiss Health Valley, at the end of the BioAlps Networking Day. The Swiss Cancer Center Léman was awarded the BioAlps Academia Award 2024. Prof. George Coukos, Prof. Olivier Michielin and Prof. Pierre-Yves…
Read MoreTakeda Neuchâtel receives the BioAlps Industry Award 2024
The BioAlps Awards 2024 ceremony took place on 21 November 2024 at the University of Fribourg in front of around 250 key players from the Swiss Health Valley, at the end of the BioAlps Networking Day. The Neuchâtel site of the Japanese biotech company Takeda received the BioAlps Industry Prize 2024. Takeda Neuchâtel produces…
Read MoreONWARD Medical Awarded Grant to Study Potential for ARC-BCI Therapy to Restore Movement after Stroke
ONWARD Medical, the Lausanne-born medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), announces a grant from the European Innovation Council (EIC) to study the use of its investigational ARC-BCI Therapy to restore upper limb movement after subcortical stroke. While…
Read MoreFIT supports 2 new life sciences projects
Gynecare+ and its innovative outfit to transform the experience of gynaecological examinations, TOCx and its digital platform for the care of patients suffering from obsessive-compulsive disorders, have received a FIT Impact Grant worth CHF 10,000. GYNECARE+, an innovative garment to transform the experience of gynaecological consultations Going to a gynaecological appointment is not…
Read MoreCSEM: 40 years of innovation
The Swiss Centre for Electronics and Microtechnology (CSEM) celebrates its 40th anniversary in 2024, marking four decades of innovation in key areas such as microtechnology, digitalisation, sustainability and life sciences. Founded in 1984 in Neuchâtel, the CSEM has become a benchmark in Switzerland and internationally for its expertise in cutting-edge technologies, including renewable…
Read MoreBracco invests EUR 80 Million in Geneva
Over 80 million euros have been invested to build Hexagon, a new multi-functional building located next to the historical 1997 plant in Plan-les-Ouates (Geneva – Switzerland). On 6 November 2024, Bracco inaugurated a new 4-story building characterized by contemporary design and constructed according to the most rigorous sustainability standards in Geneva, which will,…
Read MoreEgg or Chicken, who was the first?
Researchers have studied a single-celled organism discovered in Hawaii in 2017. The results have shed some light on this question. Who was the first? The egg or the chicken? Scientists at the University of Geneva (UNIGE) believe they have found the answer to this age-old question. They think it was the egg. The…
Read MoreEPFL Innogrants: 4 life sciences projects awarded
EPFL’s Startup Launchpad has awarded CHF 100,000 Innogrants to start-up projects based at EPFL: Myriad Optics, Protonica, Dexterous Catheters and Biomatics. Myriad Optics Myriad Optics is ensuring food safety from farm to fork, thanks to the quick and accurate detection and identification of bacterial pathogens in the food industry. Food contamination can have…
Read MoreLonza to Expand Bioconjugation in Visp with Two Additional Manufacturing Suites
Fantastic news for the Swiss Health Valley! After announcing the creation of 100 new jobs in October, Lonza announces the increase of its bioconjugation capabilities with two additional manufacturing sites in Visp (Valais). 200 other new jobs will be created. Lonza, a global development and manufacturing partner to the pharmaceutical, biotech and nutraceutical…
Read More